SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023672
Filing Date
2022-06-21
Accepted
2022-06-21 07:32:47
Documents
12
Period of Report
2022-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K logc-8k_20220617.htm   iXBRL 8-K 59605
  Complete submission text file 0001564590-22-023672.txt   193132

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA logc-20220617.xsd EX-101.SCH 5589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220617_lab.xml EX-101.LAB 20063
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220617_pre.xml EX-101.PRE 11934
6 EXTRACTED XBRL INSTANCE DOCUMENT logc-8k_20220617_htm.xml XML 3682
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 221026055
SIC: 2836 Biological Products, (No Diagnostic Substances)